NF2 and neoplasm: Finally, the fourth hit (third step) involves a tumour-specific pathogenic variant of the NF2 gene located in cis to the SMARCB1 germline PV that leads to biallelic NF2 inactivation driving schwannoma development (Fig. 4A).